Zydus JV to set up Sri Lanka pharma plant with $20M investment

Zydus Sunshine Lifesciences (Pvt) Ltd, a joint venture between Zydus Lifesciences Limited and Sunshine Healthcare (part of Sunshine Holdings PLC), has signed an agreement with the Board of Investment of Sri Lanka. The agreement is to establish a pharmaceutical manufacturing facility in the BOI zone in Horana, Sri Lanka. The project involves a phased investment exceeding USD 20 million and will be developed on nearly four acres. Commercial operations are anticipated to begin in 2028, pending project timelines and regulatory approvals. Initially, the facility will produce oral solid dosage forms for the Sri Lankan market. This investment aims to bolster Zydus' international presence, enhance access to quality medicines, and strengthen Sri Lanka's medicine supply chain resilience.